Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
Taylor Morrison Home
TMHC
KB Home
KBH
US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 2.350
- -0.050-2.08%
Close Mar 28 16:00 ET
- 2.350
- 0.0000.00%
Post 20:01 ET
150.47MMarket Cap-1.78P/E (TTM)
2.370High2.250Low986.35KVolume2.370Open2.400Pre Close2.29MTurnover3.15%Turnover RatioLossP/E (Static)64.03MShares11.20052wk High0.88P/B73.66MFloat Cap2.19052wk Low--Dividend TTM31.35MShs Float664.320Historical High--Div YieldTTM5.00%Amplitude1.530Historical Low2.320Avg Price1Lot Size
Larimar Therapeutics News
Larimar Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Larimar Therapeutics | 10-K: FY2024 Annual Report
Larimar Therapeutics | 8-K: Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Larimar Therapeutics | SCHEDULE 13G: Others
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BEN-MAIMON CAROLE
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clayton Russell
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shankar Gopi
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Celano Michael
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | SCHEDULE 13G/A: Others
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Owl Capital Holdings LP(6.53%)
Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(8.7%),Janus Henderson Biotech Innovation Master Fund Ltd(7.5%)
Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Verition Fund Management LLC(0.9%),Nicholas Maounis(0.9%)
Larimar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(7.0 %),GOLDMAN SACHS & CO. LLC(7.0 %)
Larimar Therapeutics | 10-Q: Q3 2024 Earnings Report
Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Larimar Therapeutics | 10-Q: Q2 2024 Earnings Report
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.